SCHEMBL6912855

SCHEMBL6912855

CNCc1cccc2cccnc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR5A P47898 4/20 0.54
HDAC6 Q9UBN7 2/20 0.50
MAPT P10636 4/20 0.49
MEN1 O00255 3/20 0.49
ALDH1A1 P00352 3/20 0.49
KMT2A Q03164 3/20 0.49
KDM4E B2RXH2 2/20 0.49
NSD2 O96028 1/20 0.49
BLM P54132 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
HTT P42858 3/20 0.48
MMP2 P08253 2/20 0.48
TSHR P16473 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
ALOX15 P16050 2/20 0.48
LMNA P02545 2/20 0.48
GMNN O75496 1/20 0.48
TP53 P04637 1/20 0.48
HSP90AA1 P07900 1/20 0.48
CYP3A4 P08684 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28879821 0.81 HTR5A (0.50) HTR5AHDAC6MAPTMEN1ALDH1A1
SCHEMBL14414488 0.80 EGLN1 (0.51) MAPTMEN1ALDH1A1KMT2AKDM4E
SCHEMBL11497619 0.80 HDAC6 (0.47) HTR5AHDAC6MAPTMEN1ALDH1A1
SCHEMBL643810 0.79 KDM4E (0.54) HTR5AHDAC6MAPTALDH1A1KDM4E
SCHEMBL20138518 0.77 HDAC6 (0.60) HTR5AHDAC6MAPTMEN1ALDH1A1
SCHEMBL14288545 0.77 HTR5A (0.60) HTR5AHDAC6MAPTMEN1ALDH1A1
SCHEMBL15625164 0.77 HDAC6 (0.64) HTR5AHDAC6MAPTMEN1ALDH1A1
Water SCHEMBL15271605 0.77 MMP2 (0.52) HTR5AHDAC6MAPTMEN1ALDH1A1
SCHEMBL661556 0.76 HTR5A (0.52) HTR5AHDAC6MAPTMEN1ALDH1A1
SCHEMBL1285337 0.76 HDAC6 (0.52) HTR5AHDAC6ALDH1A1LMNAADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458444-B1 HISTONE DEACETYLASE 6 INHIBITORS AND USE THEREOF UNIV TAIPEI MEDICAL (TW) 2022-06-22 EP disclosed
US-10036971-B2 Charging member, process cartridge, and electrophotographic image forming apparatus CANON KABUSHIKI KAISHA (JP) 2018-07-31 US disclosed
US-10036971-B2 Charging member, process cartridge, and electrophotographic image forming apparatus CANON KABUSHIKI KAISHA (JP) 2018-07-31 US disclosed
US-9885971-B2 Charging member, process cartridge, and electrophotographic image forming apparatus CANON KABUSHIKI KAISHA (JP) 2018-02-06 US disclosed
US-9885971-B2 Charging member, process cartridge, and electrophotographic image forming apparatus CANON KABUSHIKI KAISHA (JP) 2018-02-06 US disclosed
US-20160378011-A1 CHARGING MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2016-12-29 US disclosed
US-20160299450-A1 CHARGING MEMBER, PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS CANON KABUSHIKI KAISHA (JP) 2016-10-13 US disclosed
US-20160299450-A1 CHARGING MEMBER, PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC APPARATUS CANON KABUSHIKI KAISHA (JP) 2016-10-13 US disclosed
US-20160299451-A1 CHARGING MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2016-10-13 US disclosed
US-20160299451-A1 CHARGING MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2016-10-13 US disclosed
US-20150331348-A1 CHARGING MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2015-11-19 US disclosed
US-20150331348-A1 CHARGING MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2015-11-19 US disclosed
WO-2015032286-A1 TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F.HOFFMANN-LA ROCHE AG (CH) 2015-03-12 WO disclosed
WO-2011049731-A1 QUINOLINONE-PYRAZOLONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME CORP. (US) 2011-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10036971-B2 Charging member, process cartridge, and electrophotographic image forming apparatus GNG2, NRAS, ARFGEF1 HTR5A 3462/4885HDAC6 3703/4885MAPT 3572/4885
US-20150331348-A1 CHARGING MEMBER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS GNG2, NRAS, ARFGEF1 HTR5A 3462/4885HDAC6 3703/4885MAPT 3572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.